Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau

Author:

Rizzetto Giulio,Diotallevi Federico,Molinelli Elisa,Radi Giulia,Offidani Anna Maria

Abstract

<b><i>Introduction:</i></b> Acrodermatitis continua of Hallopeau (ACH) is a rare, chronic, and recurrent form of pustular psoriasis (PP) localized to one or more digits. Due to the rarity of ACH, no clear treatment guidelines are currently available, making the therapeutic approach more complex. <b><i>Case Presentation:</i></b> We report the first case of a young woman with ACH who was successfully treated with certolizumab pegol (CZP). <b><i>Discussion/Conclusion:</i></b> PP and ACH are difficult to treat, and biologics may be an option more manageable than cyclosporine. CZP is the safest biologic therapy during pregnancy, so there is low risk in prescribing it in women with childbearing potential. However, continuing biological therapy during pregnancy always involves an assessment of the clinical benefits, which must outweigh the risks.

Publisher

S. Karger AG

Subject

Dermatology

Reference7 articles.

1. Bachelez H. Pustular psoriasis and related pustular skin diseases. Br J Dermatol. 2018;178(3):614–8.

2. Sehgal VN, Verma P, Sharma S, Srivastava G, Aggarwal AK, Rasool F, et al. Acrodermatitis continua of hallopeau: evolution of treatment options. Int J Dermatol. 2011;50(10):1195–211.

3. Korman AM, Rzepka PV, Sopkovich JA. Acrodermatitis continua of hallopeau. JAMA Dermatol. 2018;154(11):1346.

4. Maliyar K, Crowley EL, Rodriguez-Bolanos F, OʼToole A, Gooderham MJ. The use of biologic therapy in the treatment of acrodermatitis continua of hallopeau: a review. J Cutan Med Surg. 2019 Jul/Aug;23(4):428–35.

5. Mizutani Y, Mizutani YH, Matsuyama K, Kawamura M, Fujii A, Shu E, et al. Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol. J Dermatol. 2020 Jul;47(7):e262–3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3